Bringing clinically-validated AI to outpatients

At AlgoDx, we stand behind the hypothesis that data and AI based predictions can be used to dramatically improve outpatient care in specific diagnoses. This is why we partner up with relevant stakeholders in scientific consortia looking to improve the outpatient experience. In this context, AlgoDx brings AI and regulatory expertise, with the goal to develop medical software that improves patient outcomes.

AlgoDx outpatient clinical pipeline as of May 2022

                            
Pre-Clinical
R&D
 
Regulatory Clearance
EU & US
 
Clinical validation
in outpatients
 
Post-marketing clinical follow-up
 
Ulcerative Colitis                                      
Crohn's disease                                     
Undisclosed Therapeutic Indication                                      
Ongoing
Complete

           

Clinical trials – AlgoDx sponsored clinical research

For more information on our ongoing clinical projects, visit clinicaltrials.gov